TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Percell Biolytica AB
Closing information (x1000 DKK)
Closing information | 2024/08 | 2023/08 | 2022/08 |
Turnover |
5,700
|
366 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
4,302
|
677 | |
EBITDA |
4,326
|
-908 | |
Total assets |
3,148
|
7,789 | |
Current assets |
2,871
|
7,448 | |
Current liabilities |
859
|
833 | |
Equity capital |
1,987
|
6,557 | |
- share capital |
63
|
70 | |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Solvency |
63.1%
|
84.2% | |
Turnover per employee |
2,850
|
183 | |
Profit as a percentage of turnover |
75.5%
|
185.0% | |
Return on assets (ROA) |
136.7%
|
8.7% | |
Current ratio |
334.2%
|
894.1% | |
Return on equity (ROE) |
216.5%
|
10.3% | |
Change turnover |
5,369
|
-655 | |
Change turnover % |
-36%
|
1622%
|
-64% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.